Product Pipeline
| Arterial Disease | Infection Prevention | Wound Management |
| The Market | The Market | The Market |
| “The potential annual market for a synthetic bypass graft could exceed $1.5 billion” — URI Pacer Magazine, April 2005 | “It is estimated that the market for biocompatible materials, materials that make contact with the body, will be almost $12 billion by 2008″ — Biocompatible Materials for the Human Body, 2003. | The current market for wound dressings is $300 million annually. Therefore, entry into this market will be easier for significantly improved product designs which incorporate clinically-approved materials/agents. |
| BioSurfaces The Solution | BioSurfaces The Solution | BioSurfaces The Solution |
| “With a grant from the National Heart, Lung and Blood Institute of the National Institutes of Health, the BioSurfaces team is working on new way to synthesize small-diameter artificial arteries (less than 5 millimeters) with material made of polyester and collagen”– URI Pacer Magazine, April 2005 | “With an average cost to treat an infection at $2,300 and an infection rate of 14%-16%, the potential cost savings for the US healthcare system is on the order of $5 billion” BioSurfaces, 2007. | “BioSurfaces Building Better Bandage, Artificial Arteries” — Mass High Tech Magazine, March, 2005 |
| Artificial Artery (BioSpunTM Vascular Graft)
Ventricular Assist Device Conduit (BioSpunTM -VAD) |
Infection-Resistant Suture (DyeBond ABTM Suture) | Bioactive Wound Dressing (BioCompleteTM Wound Pak) |
 |
 |
 |